SCHEMBL6002332

SCHEMBL6002332

CCCc1cc2[c]cccc2o1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.33
TLR8 Q9NR97 1/20 0.33
PPARG P37231 1/20 0.31
ALOX15 P16050 1/20 0.31
LOXL2 Q9Y4K0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3313831 0.79 HDAC6 (0.35) LOXL2
SCHEMBL9600991 0.75
SCHEMBL16048100 0.72 STS (0.31) STSTLR8
SCHEMBL496066 0.72 CYP1A2 (0.31) ALOX15
SCHEMBL16049260 0.71 STS (0.30) STS
SCHEMBL6013090 0.71 LOXL2 (0.60) TLR8LOXL2
SCHEMBL3315549 0.68
SCHEMBL16047680 0.68 LOXL2 (0.31) LOXL2
SCHEMBL3307999 0.66 EPHX2 (0.34)
SCHEMBL3715533 0.66 PPARG (0.69) STSPPARGALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed